A Minimally Replicative HIV-2 Live-Virus Vaccine ProtectsM. nemestrinafrom Disease after HIV-2 287 Challenge

Author： Looney D.J.   McClure J.   Kent S.J.   Radaelli A.   Kraus G.   Schmidt A.   Steffy K.   Greenberg P.   Hu S.-L.   Morton W.R.   Wong-Staal F.  

Publisher： Elsevier

ISSN： 0042-6822

Source： Virology, Vol.242, Iss.1, 1998-03, pp. : 150-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using SHIVs to develop an anti-HIV-1 live-attenuated vaccine

By Kuwata T.   Miura T.   Hayami M.  

Trends in Microbiology, Vol. 9, Iss. 10, 2001-10 ,pp. : 475-480

Elsevier

Access to resources Recommend Favorite

Interaction with Human Immunodeficiency Virus (HIV) Type 2 Predicts HIV Type 1 Genotype

By Sarr A.D.   Sankale J.-L.   Hamel D.J.   Travers K.U.   Gueye-Ndiaye A.   Essex M.   Mboup S.   Kanki P.J.  

Virology, Vol. 268, Iss. 2, 2000-03 ,pp. : 402-410

Elsevier

Access to resources Recommend Favorite

Evaluation of a Live-Attenuated Foot-and-Mouth Disease Virus as a Vaccine Candidate

By MASON P.W.   PICCONE M.E.   MCKENNA T.S.-C.   CHINSANGARAM J.   GRUBMAN M.J.  

Virology, Vol. 227, Iss. 1, 1997-01 ,pp. : 96-102

Elsevier

Access to resources Recommend Favorite

Genomic RNA Packaging in HIV-1 and HIV-2

By  

Virus Research, Vol. 77, Iss. 2, 2001-10 ,pp. : 134-137

Elsevier

Access to resources Recommend Favorite

Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus

By Girard M.   van der Ryst E.   Barre-Sinoussi F.   Nara P.   Tartaglia J.   Paoletti E.   Blondeau C.   Jennings M.   Verrier F.   Meignier B.   Fultz P.N.  

Virology, Vol. 232, Iss. 1, 1997-05 ,pp. : 98-104

Elsevier

Access to resources Recommend Favorite